Suppr超能文献

痣相关黑色素瘤:事实与争议。

Nevus-associated melanoma: facts and controversies.

机构信息

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Unit of Pathology, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

出版信息

G Ital Dermatol Venereol. 2020 Feb;155(1):65-75. doi: 10.23736/S0392-0488.19.06534-9.

Abstract

Nevus-associated melanoma (NAM) is defined on histopathological basis by the coexistence of melanoma and nevus components. Melanomas developing on pre-existing congenital or acquired nevi are usually of the superficial spreading subtype and harbor the BRAFV600E mutation. NAM accounts for almost one-third of melanoma cases As compared to de novo melanoma, NAM develops on younger patients, is more frequently located on the trunk, and is associated with a high nevus count, light eye color and history of frequent sunburns. NAM has been regarded as a model to investigate melanoma origin. Molecular analysis defining the mutation profile of NAM's nevus and melanoma components supported the existence of two pathways of melanoma development, the first not involving clinically visible precursors, the second involving melanocytic nevi as precursors. Concerning diagnosis, dermatoscopy may identify nevus and melanoma components when located side-by-side, but no specific criteria have been described when superimposed. In-vivo reflectance confocal microscopy significantly enhances the recognition of NAM by allowing the detection of nevus remnants when superficially located. Regarding prognosis, NAM is generally thinner and more frequently in-situ than de-novo melanoma. Furthermore, studies reporting survival analysis demonstrated a trend towards better overall, distant-metastasis-free and recurrence-free survival. Although a clinical, phenotypic and molecular profile of NAM has been defined, controversies still exist. In the current review, we widely report and discuss facts and controversies on NAM.

摘要

痣相关黑色素瘤(NAM)在组织病理学基础上通过黑色素瘤和痣成分的共存来定义。在先前存在的先天性或获得性痣上发展的黑色素瘤通常为浅表扩散型,并且携带 BRAFV600E 突变。NAM 占黑色素瘤病例的近三分之一。与新发黑色素瘤相比,NAM 发生在更年轻的患者中,更常位于躯干上,并且与高痣计数、浅色眼睛和频繁晒伤史有关。NAM 一直被认为是研究黑色素瘤起源的模型。定义 NAM 的痣和黑色素瘤成分突变谱的分子分析支持黑色素瘤发展的两种途径的存在,第一种途径不涉及临床上可见的前体,第二种途径涉及黑素细胞痣作为前体。关于诊断,当痣和黑色素瘤成分位于并排时,皮肤镜可能识别它们,但当它们重叠时,尚未描述具体标准。体内反射共聚焦显微镜通过允许检测位于表面的痣残留,显著提高了对 NAM 的识别。关于预后,NAM 通常比新发黑色素瘤更薄,更常原位。此外,报告生存分析的研究表明,总体、远处转移无病和无复发生存率有改善的趋势。尽管已经定义了 NAM 的临床、表型和分子特征,但仍存在争议。在本次综述中,我们广泛报告和讨论了关于 NAM 的事实和争议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验